Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes

被引:43
作者
Kumar, Bhavna
Cipolla, Michael J.
Old, Matthew O.
Brown, Nicole V.
Kang, Stephen Y.
Dziegielewski, Peter T.
Durmus, Kasim
Ozer, Enver
Agrawal, Amit
Carrau, Ricardo L.
Schuller, David E.
Leon, Marino E.
Pan, Quintin
Kumar, Pawan
Wood, Valerie
Burgers, Jessica
Wakely, Paul E., Jr.
Teknos, Theodoros N. [1 ,2 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, James Canc Hosp, Dept Otolaryngol Head & Neck Surg, 915 Olentangy River Rd,Suite 4000, Columbus, OH 43212 USA
[2] Ohio State Univ, Wexner Med Ctr, Solove Res Inst, 915 Olentangy River Rd,Suite 4000, Columbus, OH 43212 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2016年 / 38卷
关键词
surgery oropharynx; oropharyngeal cancer; human papillomavirus; squamous cell carcinoma; transoral surgery; TRANSORAL ROBOTIC SURGERY; QUALITY-OF-LIFE; LOCALLY ADVANCED HEAD; PHASE-III TRIAL; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RADIATION-THERAPY; CONCOMITANT CHEMOTHERAPY; RANDOMIZED-TRIAL; CHEMORADIATION;
D O I
10.1002/hed.24319
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to further define the impact of primary surgery in the management of oropharyngeal squamous cell carcinoma (SCC). Methods. Two hundred ninety-six patients with oropharyngeal SCC treated with primary surgery were included. Multivariable analysis and recursive partitioning analysis (RPA) identified predictors of survival and gastrostomy tube presence. Results. Multivariable analysis identified that HPV negativity (p = .0002), presence of extranodal extension (p = .0025), and advanced T classification (p = .0081) were independent predictors of survival. For HPV-positive patients, surgical approach (p = .0111) and margin status (p = .0287) were significant predictors of survival. For HPV-negative patients, extranodal extension (p = .0021) and advanced T classification (p = .0342) were significant predictors of survival. Smoking status and advanced neck disease did not impact survival, and the addition of adjuvant chemotherapy did not confer survival benefit in HPV-positive or HPV-negative subgroups. Conclusion. Independent predictors of survival are unique in patients with oropharyngeal SCC treated with primary surgery. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:E1794 / E1802
页数:9
相关论文
共 41 条
  • [1] Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
    Ang, K. Kian
    Harris, Jonathan
    Wheeler, Richard
    Weber, Randal
    Rosenthal, David I.
    Nguyen-Tan, Phuc Felix
    Westra, William H.
    Chung, Christine H.
    Jordan, Richard C.
    Lu, Charles
    Kim, Harold
    Axelrod, Rita
    Silverman, C. Craig
    Redmond, Kevin P.
    Gillison, Maura L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) : 24 - 35
  • [2] [Anonymous], RPART RECURSIVE PART
  • [3] [Anonymous], 2020, R LANG ENV STAT COMP
  • [4] Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
    Bernier, J
    Domenge, C
    Ozsahin, M
    Matuszewska, K
    Lefèbvre, JL
    Greiner, RH
    Giralt, J
    Maingon, P
    Rolland, F
    Bolla, M
    Cognetti, F
    Bourhis, J
    Kirkpatrick, A
    van Glabbeke, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) : 1945 - 1952
  • [5] FACTORS ASSOCIATED WITH PHARYNGOESOPHAGEAL STRICTURE IN PATIENTS TREATED WITH CONCURRENT CHEMOTHERAPY AND RADIATION THERAPY FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
    Best, Simon R.
    Ha, Patrick K.
    Blanco, Ray G.
    Saunders, John R., Jr.
    Zinreich, Eva S.
    Levine, Marshall A.
    Pai, Sara I.
    Walker, Melissa
    Trachta, Jaclyn
    Ulmer, Karen
    Murakami, Peter
    Thompson, Richard
    Califano, Joseph A.
    Messing, Barbara P.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (12): : 1727 - 1734
  • [6] Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
    Calais, G
    Alfonsi, M
    Bardet, E
    Sire, C
    Germain, T
    Bergerot, P
    Rhein, B
    Tortochaux, J
    Oudinot, P
    Bertrand, P
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (24) : 2081 - 2086
  • [7] Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
    Chaturvedi, Anil K.
    Anderson, William F.
    Lortet-Tieulent, Joannie
    Curado, Maria Paula
    Ferlay, Jacques
    Franceschi, Silvia
    Rosenberg, Philip S.
    Bray, Freddie
    Gillison, Maura L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (36) : 4550 - 4559
  • [8] Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Cooper, JS
    Pajak, TF
    Forastiere, AA
    Jacobs, J
    Campbell, BH
    Saxman, SB
    Kish, JA
    Kim, HE
    Cmelak, AJ
    Rotman, M
    Machtay, M
    Ensley, JF
    Chao, KSC
    Schultz, CJ
    Lee, N
    Fu, KK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) : 1937 - 1944
  • [9] Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma
    Denis, F
    Garaud, P
    Bardet, E
    Alfonsi, M
    Sire, C
    Germain, T
    Bergerot, P
    Rhein, B
    Tortochaux, J
    Calais, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 69 - 76
  • [10] Intensity-Modulated Chemoradiotherapy Aiming to Reduce Dysphagia in Patients With Oropharyngeal Cancer: Clinical and Functional Results
    Feng, Felix Y.
    Kim, Hyungjin M.
    Lyden, Teresa H.
    Haxer, Marc J.
    Worden, Francis P.
    Feng, Mary
    Moyer, Jeffrey S.
    Prince, Mark E.
    Carey, Thomas E.
    Wolf, Gregory T.
    Bradford, Carol R.
    Chepeha, Douglas B.
    Eisbruch, Avraham
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2732 - 2738